Last month, the Australian Bureau of Statistics (ABS) released a report of mortality statistics. It showed that from January to July 2022, there were 17% more deaths (16,375) than the average expected for these months.
The pros and cons of a 5th jab for health workers, whether we have reached the end of the road with mRNA-based vaccines, cutting through the subvariant hype, new vaccines on the horizon, and the 2023 forecast - does ATAGI need a rethink?
In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).
Entering a new wave driven by a soup of Omicron sub-variants, where more than 5 million Australians eligible for boosters have not received them, and how we must encourage patients to get their boosters, with the bivalent vaccines being more effective
New COVID variants BQ.1 and XBB now account for 10% of Victoria’s case numbers, and are expected to overtake BA.5 as the dominant Omicron variant in Australia.
The new COVID wave comprising of BQ1, XBB and other variants, and what our frontline response should look like, whether a fifth booster is worth having, children's vaccination developments and an update on the antivirals
How resources are being diverted to COVID-19, and how they have been affecting Tuberculosis resources, knowing when to suspect and diagnose active Tuberculosis and how to manage the patient